Is this email not displaying correctly? View it in your browser.
 
Newswise - News for JournalistsNewswise - pix
Newswise Special Wire
Tuesday, December 17, 2019

Public edition | newswise.com

Newswise Cancer Research Wire for 17-Dec-2019
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.


Cancer Research


Nilotinib Appears Safe In Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment

A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of ne...

– Georgetown University Medical Center

NIH UL1-TR001409; JAMA Neurology

Embargo expired on 16-Dec-2019 at 11:00 ET


Mayo Clinic researchers look at post menopause as key factor in endometrial cancer

Endometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer incidence rates are on the rise in the western world, suggesting that alterations in environment...

– Mayo Clinic

Scientific Reports; Uterine microbiome study

Embargo expired on 16-Dec-2019 at 05:00 ET


BCMA-Targeted Immunotherapy Can Lead to Durable Responses in Multiple Myeloma

An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma patients whose disease has relapsed or is resistant to other standard therapies

– Perelman School of Medicine at the University of Pennsylvania

Lancet Oncology

Embargo expired on 16-Dec-2019 at 18:30 ET


Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer

Researchers from The University of Texas MD Anderson Cancer Center have identified a standardized protocol that uses image-guided breast biopsies to reliably predict residual disease in breast cancer patients and that potentially identifies exception...

– University of Texas M. D. Anderson Cancer Center

2019 San Antonio Breast Cancer Symposium

Embargo expired on 13-Dec-2019 at 11:30 ET


Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Researchers from The University of Texas MD Anderson Cancer Center today reported results from a pooled analysis of more than 5,100 breast cancer patients that found residual cancer burden (RCB) continuous index and classification were independently ...

– University of Texas M. D. Anderson Cancer Center

2019 San Antonio Breast Cancer Symposium

Embargo expired on 13-Dec-2019 at 08:30 ET


Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall ...

– University of Texas M. D. Anderson Cancer Center

2019 San Antonio Breast Cancer Symposium

Embargo expired on 11-Dec-2019 at 09:45 ET


Moffitt Cancer Center Researchers Develop More Efficient Approach to Create Mouse Models

Moffitt Cancer Center researchers have developed a new platform for creating genetically engineered mice to study melanoma that is significantly faster than a normal mouse model approach.

– Moffitt Cancer Center

Cancer Research, Nov-2019


Novel Cell-Based Therapy Induces Cell Death in Sensitive and Resistant Non-Hodgkin Lymphoma Models

Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensit...

– Rutgers Cancer Institute of New Jersey

Leukemia


Math Equation Predicts and Detects Liver Cancer

University of California San Diego School of Medicine and Moores Cancer Center researchers developed a math equation to predict and detect liver cancer and identified when healthy cells become cancerous.

– University of California San Diego Health

Proceedings of the National Academy of Science


The Rapid Tissue Donation Program at Moffitt Cancer Center Offers a Feasible Approach to Improve Research

In an article published in Cancer Medicine, Moffitt Cancer Center scientists describe a community-based program called the Rapid Tissue Donation (RTD) protocol. It enables patients to consent to donating tumor tissue and blood samples for research pu...

– Moffitt Cancer Center

Cancer Medicine, Nov-2019


Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective

Rutgers Cancer Institute of New Jersey investigators evaluated all treatment strategies for both standard-risk and good-risk ductal carcinoma in-situ and found the most commonly recommended combination treatment for DCIS represents low-value care, wh...

– Rutgers Cancer Institute of New Jersey

San Antonio Breast Cancer Symposium, Dec-2019


Criteria for Clinical Trials Might Be Too Strict, Needlessly Excluding Patients

Federal regulations may keep lung cancer patients out of clinical trials simply because these patients are on medications that might affect the electrical system of the heart.

– UT Southwestern Medical Center

Clinical Lung Cancer


病例报告:干细胞可加改善髓损伤后的运动和感觉功能

Mayo Clinic的一项早期研究显示,源自患者自身脂肪的干细胞可进一步改善(而不仅是稳定)脊髓损伤患者的运动和感觉功能。

– Mayo Clinic


Researchers create accurate model of organ scarring using stem cells in a lab

A team led by Dr. Brigitte Gomperts at UCLA has developed a “scar in a dish” model that uses multiple types of cells derived from human stem cells to closely mimic the progressive scarring that occurs in human organs. The researchers used this mo...

– University of California, Los Angeles (UCLA), Health Sciences

Cell Reports


Dense breasts and breast cancer: What every woman needs to know

Two new laws targeting breast cancer screenings and dense breasts have been passed in Illinois since 2018. Still, many women don’t know whether they have dense breasts and how that affects breast cancer screenings — despite roughly half of all wo...

– University of Chicago Medical Center


Cancer Experts and Features


Virginia Mason Experts Assess Breath Test to Detect Esophageal Cancer

Research is beginning at Virginia Mason Medical Center that will evaluate the accuracy of a breath test for detecting esophageal cancer, one of the fastest growing and deadliest cancers in the United States.

– Virginia Mason Medical Center

JAMA Oncol. 2018 Jul; 4(7): 970–976.


Study on Negative Perception of Support Groups Garners Research Paper Award

A study on the negative perception of support groups among older breast cancer survivors was selected as a 2019 Best Original Research Paper in the journal Cancer Nursing.

– UCLA School of Nursing

Cancer Nursing


Managing the Holidays with a Long-Term Illness

Leora Lowenthal, LICSW-OSW-C, manager of the oncology social work program at BIDMC, and Hester Hill Schnipper, LICSW, OSW-C, provide advice on rethinking holiday traditions and celebrations to capture more peace in the face of a long-term illness.

Expert Available

– Beth Israel Deaconess Medical Center


ASTRO applauds Senate confirmation of Dr. Stephen Hahn as U.S. Food and Drug Administration Commissioner

The American Society for Radiation Oncology (ASTRO) applauded the U.S. Senate for voting today to confirm radiation oncologist Stephen Hahn, MD, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA).

– American Society for Radiation Oncology (ASTRO)


Closing Gaps in Perspective of Value between Cancer Patients and their Health Care Providers

NCCN hosted an annual NCCN Patient Advocacy Summit: Delivering Value for Patients across the Oncology Ecosystem in Washington, DC, bringing together patients, advocates, clinicians, policy-makers, and others to share diverse perspectives on the meani...

– National Comprehensive Cancer Network® (NCCN®)


New Year's Resolution: Quitting Smoking

An expert from the Rutgers Tobacco Dependence Program shares info and resources on how to quit smoking in the new year.

– Rutgers Cancer Institute of New Jersey


Cancer Announcements


Elizabeth Fox, M.D., named senior vice president of clinical trials research

St. Jude Children’s Research Hospital announced today that Elizabeth Fox, M.D., has been named senior vice president of clinical trials research.

– St. Jude Children's Research Hospital


Thomas Gajewski receives immuno-oncology award from ESMO

The European Society for Medical Oncology (ESMO) has named Thomas Gajewski, MD, PhD, Abbvie Foundation Professor of Cancer Immunotherapy in the Ben May Department for Cancer Research and Professor of Pathology and Medicine at the University of Chicag...

– University of Chicago Medical Center


Clinical Research Pathways Partners with WellStar Health System to Increase Diversity in Clinical Trials

Clinical Research Pathways, an Atlanta-based non-profit, announces a grant to Wellstar Health System designed to increase diversity in oncology-related clinical trials

– Clinical Research Pathways


NAU receives $6.83 million grant to continue community-based Native American cancer prevention program

In the next five years, the NACP will focus the program's immediate priorities on enhancing the partnership with the University of Arizona Cancer Center to make a greater impact in addressing cancer health disparities for Native Americans in Arizona ...

– Northern Arizona University


Jersey Shore University Medical Center Receives Re-Accreditation from the National Accreditation Program for Breast Centers

Hackensack Meridian Health Jersey Shore University Medical Center achieved re-accreditation from the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.

– Hackensack Meridian Health


A New Era of Care: The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center to Open in January 2020

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care nex...

– Memorial Sloan Kettering Cancer Center

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 UT Southwestern Medical Center

 University of California, Los Angeles (UCLA), Health Sciences

 University of Texas M. D. Anderson Cancer Center

 University of California San Diego Health


Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us